Company / Free Cash Flow per Share
Avidity Biosciences, Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$4.82
FY2025
5-year range
-$4.82 / -$1.69
FY2021-FY2025
Trend
-74.7%
vs FY2024
Sector context
#174 of 192
Health Care
What the data says
Among 192 Health Care companies, Avidity Biosciences, Inc. is in the bottom 9% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 8 years, ranging from $-4.82 in FY2025 to $0.83 in FY2019.
Based on SEC 10-K filings.
-4.82 in FY2025.
Declined from $-1.69 to $-4.82 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 192This company -$4.82 Sector average -$19.84
▼
+75.7% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 74.7% year-over-year.
- Ranks #174 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.82 | -74.7% |
| FY2024 | -$2.76 | -63.4% |
| FY2023 | -$1.69 | +36.7% |
| FY2022 | -$2.67 | -12.1% |
| FY2021 | -$2.38 | -34.9% |
| FY2020 | -$1.76 | -312.2% |
| FY2019 | $0.83 | +121.2% |
| FY2018 | -$3.92 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026